Societal Preferences, Values and Priorities for Genomic Testing for Atrial Fibrillation: Evidence from Two Discrete Choice Experiments
Genomic testing for atrial fibrillation has perceived value for symptomatic patients and at-risk relatives. Tailored educational programmes and targeted support are essential to improve access for socioeconomically disadvantaged groups.
Authors
- Ilias Goranitis (ORCID: https://orcid.org/0000-0001-7946-8324)
- Stephanie Best (ORCID: https://orcid.org/0000-0002-1107-8976)
- Min Li (ORCID: https://orcid.org/0000-0002-0072-5912)
- D Fatkin
Institutions
- The University of Melbourne (AU)
- Victor Chang Cardiac Research Institute (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- Murdoch Children's Research Institute (AU)
- Melbourne Health (AU)
Publication Details
- Journal
- Patient
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1007/s40271-026-00801-w
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00